Corporate News     23-Nov-22
Zydus receives USFDA approval for Famotidine Injection
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Famotidine Injection USP, 40 mg/4 mL (10 mg/mL) and 200 mg/20 mL (10 mg/mL) multiple-dose vials (USRLD: Pepcid® injection).

Famotidine Injection is indicated to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. This medication is also used to treat certain stomach and throat (esophagus) problems such as erosive esophagitis, gastroesophageal reflux disease-GERD and Zollinger-Ellison syndrome.

Famotidine Injection had annual sales of USD 1.9 mn in the United States according to IQVIA data (IQVIA MAT Sep 2022). The drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara, India.

Previous News
  Zydus Lifesciences receives USFDA approval for Azilsartan Medoxomil Tablets
 ( Corporate News - 04-Jul-24   14:54 )
  Zydus Lifesciences Ltd soars 1.83%, rises for third straight session
 ( Hot Pursuit - 08-Aug-24   13:05 )
  Zydus receives USFDA approval for Enzalutamide capsules
 ( Corporate News - 28-Sep-24   14:21 )
  Zydus Lifesciences Ltd drops for fifth straight session
 ( Hot Pursuit - 27-Jun-24   13:35 )
  Zydus Life gets final approval from USFDA for cancer drug
 ( Hot Pursuit - 28-Sep-24   14:42 )
  Zydus Life jumps on USFDA nod for BP lowering drug
 ( Hot Pursuit - 04-Jul-24   16:28 )
  Barometers end with minor gains; broader mkt outperforms
 ( Market Commentary - Quick Review 18-May-24   12:44 )
  Zydus Life Vadodara unit gets OAI report from USFDA
 ( Hot Pursuit - 19-Jul-24   09:49 )
  Zydus receives USFDA approval for Theophylline ER Tablets
 ( Corporate News - 22-May-24   12:57 )
  Board of Zydus Lifesciences to consider buyback of shares
 ( Corporate News - 05-Feb-24   18:54 )
  Zydus Lifesciences gains as board mulls share buyback
 ( Hot Pursuit - 06-Feb-24   09:33 )
Other Stories
  RACL Geartech receives ratings action from CARE
  05-Oct-24   14:24
  JHS Svendgaard Retail Ventures EGM scheduled
  05-Oct-24   13:50
  Lexus Granito (India) EGM scheduled
  05-Oct-24   13:50
  Latteys Industries EGM scheduled
  05-Oct-24   13:50
  Embassy Office Parks REIT to convene board meeting
  05-Oct-24   13:50
  Board of Fusion Micro Finance appoints director
  05-Oct-24   13:17
  Board of Fusion Micro Finance approves rights issue of Rs 550 cr
  05-Oct-24   13:15
  Bharti Airtel deploys additional spectrum in Jammu-Kashmir & Leh Ladakh
  05-Oct-24   12:53
  Dr Reddys announces incorporation of new step-down subsidiary in Denmark
  05-Oct-24   11:37
  360 ONE WAM grants 21.47 lakh stock options
  05-Oct-24   11:32
Back Top